numbers of follicles (9.7 \m=+-\0.8) and oocytes recovered (8.7 \m=+-\0.8) were at least twofold greater (P < 0.001) than those measured in the natural oestrus group (3.7 \ m=+-\0.6; 3.4 \ m=+-\0.6, respectively) or subgroups on day 2 (3.7 \ m=+-\ 0.4; 3.3 \ m=+-\0.4) and day 3 (5.7 \ m=+-\ 0.8; 5.3 \ m=+-\0.8). Overall, the proportion of eggs cleaving in vitro was similar (P > 0.05) between the natural oestrus group (48.3%) and the PMSG/hCG group (50.9%), but the latter group produced more than twice the number of embryos per donor. Embryo quality was unaffected (P > 0.05) by day of hormone treatment, and more than 80% of all two-cell embryos were rated good-to-excellent quality. In summary, there is a temporal relationship between day of sexual receptivity and follicular egg viability in the domestic cat: eggs on the first day of oestrus are not optimally responsive to an LH-like stimulus. There is also no evidence that PMSG/hCG treatment compromises egg quality or subsequent fertilizability in vitro. On the contrary, use of these gonadotrophins markedly improves overall IVF efficiency by increasing the total number of high quality embryos produced.
Introduction
One important element influencing fertilization and subsequent embryo development is the use and timing of exogenous gonadotrophins. For example, fertilization rate and resulting embryo quality are compromised in mated cats treated with commercial FSH (FSH-P; Burns-Biotec, Lincoln, NE) to induce oestrus (Goodrowe et al, 1988a) . For containing eggs that readily cleave in vitro after insemination (Goodrowe et al, 1988b; Johnston et al, 1991a, b) . However, egg viability appears closely related to the interval between administration of the two hormones; if the interval is too short or too long, egg quality and cleavage rate in vitro are markedly compromised (Goodrowe et al, 1988b; Donoghue et al, 1992) .
The sensitivity of the domestic cat egg to the interval between the FSH-like and LH-like stimulus has been an incen¬ tive for considering other possible effects of exogenous gonadotrophins on IVF. It is well known that gonadotrophin therapies are associated with reduced fertilization rates in vivo and in vitro and poor embryonic development in mice (Maudlin and Fraser, 1977; Sato and Marrs, 1986) , rats (Evans and Armstrong, 1984) , rabbits (Fujimoto et al, 1974) and sheep (Moore et al, 1985) . Problems frequently associated with exogenous gonadotrophin use in humans (ovarian hyperstimulation, cystic follicles, a perturbed endocrine milieu) have caused some to question whether IVF might be enhanced by using eggs from natural (nonhormone-stimulated) cycles (Messinis and Templeton, 1988; Osborn and Moor, 1988 (Wildt et al, 1980 (Wildt et al, , 1981 Schmidt et al, 1983) . No (Goodrowe et al, 1988b; Johnston el al, 1991a, b) and by others (Niwa et al, 1985) . These cats were monitored twice a day for 5 consecutive days after PMSG administration for overt sexual receptivity to determine whether gonadotrophin treatment induced oestrous behaviour.
Twenty-four to 26 h after hCG, all females were subjected to laparoscopie egg collection (Goodrowe et al, 1988b) and the follicular contents aspirated into collection tubes containing modified Krebs-Ringer bicarbonate medium (mKRB) (Niwa et al, 1985; Tovoda and Chang, 1986) (Goodrowe et al, 1988b; Johnston et al, 1989 Johnston et al, , 1991a Wildt, 1991 Electroejaculates (Wildt et al, 1983) were subjected to swim-up processing (Goodrowe et al, 1988b (Goodrowe et al, 1988b; Johnston et al, 1991a, b) . In this con¬ text, the cat egg is similar to that of the mouse (Gilula et al, 1978) , human (Brackett, 1985) and pig (Motlik et al, 1986) in which these same criteria are convenient indices of egg maturity and fertilization potential.
As a gonadotrophin, PMSG is a potent stimulator of ovarian follicular development in cats. When given at a high dose or in sequential injections, PMSG causes ovarian hyperstimulation and the production of cystic follicles and abnormal endocrine profiles (Colby, 1970; Wildt et al, 1978; Cline et al, 1980) . These adverse side effects are lessened using single doses < 150 iu (Niwa et al, 1985; Goodrowe et al, 1988b Goodrowe et al, , 1989 . In addition to excessive folliculogenesis, PMSG has been associ¬ ated with questionable egg quality and relatively poor IVF rates in an array of laboratory and livestock species (Fujimoto et al, 1974; Maudlin and Fraser, 1977; Evans and Armstrong, 1984; Moore et al, 1985; Sato and Marrs, 1986) . In contrast, we detected no adverse consequences of using PMSG, at the described dose, to accelerate follicular growth in cats. On the contrary, compared with results from naturally oestrous cats, the total number of eggs recovered was increased more than twice, and more PMSG-stimulated eggs met maturation criteria, thus increasing the total number of embryos produced per egg donor. The mechanism by which PMSG may contribute to egg maturation is unknown. However, a recent study compared follicular granulosa cell proliferation in spontaneously cyclic women with women treated with human menopausal gonado¬ trophin (hMG) (Gougeon and Testart, 1990 
